Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin in Hepatopulmonary Syndrome in Cirrhosis
NCT05187715Unknown
- Sponsor
- Institute of Liver and Biliary Sciences
- Start
- Feb 2022
- Primary completion
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in hepatopulmonary syndrome (HPS) comparing Simvastatin Arm with Placebo Arm (2 arms). Primary endpoint: Achievement of complete response at 6 months. Status: unknown.
02
Drugs
simvastatin
03
Conditions
hepatopulmonary syndrome (HPS)
Beyond the preview
Go deeper on NCT05187715.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05187715.